Average prices of Humira - selected countries 2017

The price for Humira in the United States was triple the price for the same drug in Germany, as of 2017. Two kits of Humira Pen (40 mg) cost an average 4,480 U.S. dollars compared to 1,570 dollars in Germany. At 1,230 dollars, the same supply was even cheaper in Switzerland, one of the most expensive countries worldwide. In general, higher drug prices are a much discussed issue in the U.S. and pharmaceutical per capita spending is significant higher here than in other developed countries.

Where Humira is used

Humira is used mostly for the treatment of rheumatoid and psoriatic arthritis. However, like many other top drugs, the range of medical conditions it can be used to treat is much larger. Thus, the drug is also used to treat Crohn’s disease, ankylosing spondylitis, ulcerative colitis, psoriasis, uveitis, and some other autoimmune diseases. Humira is administered subcutaneously via injection. It was approved for the first time in 2002 in the United States.

Humira’s impact on AbbVie

Humira is manufactured by U.S. pharmaceutical company AbbVie and generated a massive 19.9 billion U.S. dollars of total revenue during 2018. Thus, AbbVie made 60 percent of its total revenue through Humira. It was speculated if Humira would be the first drug ever to generate global sales of over 20 billion dollars. However, projections show us that this might not happen, but more likely there will be a distinct decrease in revenue until 2024.

Average prices of Humira in selected countries in 2017 (in U.S. dollars)*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until June 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

December 2019

Region

Worldwide

Survey time period

2017

Supplementary notes

* Humira Pen (Adalimumab), 2 kit, 40 mg.

Prices for the United States were estimated by the Health Care Cost Institute using claims data on the commercially insured under age 65 who obtain health insurance through their employer.
Prices for Australia, Germany, Holland, New Zealand , South Africa, Switzerland, the UAE and the UK are are derived from unpublished local industry sources, collected and collated by the iFHP.
USA prescription drug prices are average point of sale price, which reflects discounts from the wholesale price, but not manufacturer rebates.
Drug prices for the UK were derived from the 2019 British National Formulary, which form the basis for both public and private drug prices.
All prices are based on 2017 data, converted at prevailing 2017 exchange rates to US dollars.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical brands: Humira (AbbVie)"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.